openPR Logo
Press release

Global and United States Daratumumab Injection Market Report & Forecast 2022-2028

04-07-2022 08:54 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research

/ PR Agency: QY Research
This report focuses on global and United States Daratumumab Injection market, also covers the segmentation data of other regions in regional level and county level.

Global Daratumumab Injection Scope and Market Size

Daratumumab Injection market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Daratumumab Injection market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

100 mg

400 mg

Segment by Application

Hospital

Clinic

Others

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Johnson & Johnson

Xi'an Janssen Pharmaceutical

Shanghai Henlius Biotech

 

Research Objectives

To study and analyze the global Daratumumab Injectionconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Daratumumab Injectionmarket by identifying its various subsegments.
Focuses on the key global Daratumumab Injectionmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Daratumumab Injectionwith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Daratumumab Injectionsubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

 

Table of Contents

 

1 Study Coverage
1.1 Daratumumab Injection Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Introduction
1.2 Global Daratumumab Injection Outlook 2017 VS 2022 VS 2028
1.2.1 Global Daratumumab Injection Market Size for the Year 2017-2028
1.2.2 Global Daratumumab Injection Market Size for the Year 2017-2028
1.3 Daratumumab Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Daratumumab Injection in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Daratumumab Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Daratumumab Injection Market Dynamics
1.4.1 Daratumumab Injection Industry Trends
1.4.2 Daratumumab Injection Market Drivers
1.4.3 Daratumumab Injection Market Challenges
1.4.4 Daratumumab Injection Market Restraints
1.5 Study Objectives
1.6 Years Considered

2 Daratumumab Injection by Type
2.1 Daratumumab Injection Market Segment by Type
2.1.1 100 mg
2.1.2 400 mg
2.2 Global Daratumumab Injection Market Size by Type (2017, 2022 & 2028)
2.3 Global Daratumumab Injection Market Size by Type (2017-2028)
2.4 United States Daratumumab Injection Market Size by Type (2017, 2022 & 2028)
2.5 United States Daratumumab Injection Market Size by Type (2017-2028)

3 Daratumumab Injection by Application
3.1 Daratumumab Injection Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Daratumumab Injection Market Size by Application (2017, 2022 & 2028)
3.3 Global Daratumumab Injection Market Size by Application (2017-2028)
3.4 United States Daratumumab Injection Market Size by Application (2017, 2022 & 2028)
3.5 United States Daratumumab Injection Market Size by Application (2017-2028)

4 Global Daratumumab Injection Competitor Landscape by Company
4.1 Global Daratumumab Injection Market Size by Company
4.1.1 Top Global Daratumumab Injection Companies Ranked by Revenue (2021)
4.1.2 Global Daratumumab Injection Revenue by Player (2017-2022)
4.2 Global Daratumumab Injection Concentration Ratio (CR)
4.2.1 Daratumumab Injection Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Daratumumab Injection in 2021
4.2.3 Global Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Daratumumab Injection Headquarters, Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Type
4.3.1 Global Daratumumab Injection Headquarters and Area Served
4.3.2 Global Daratumumab Injection Companies Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Daratumumab Injection Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Daratumumab Injection Market Size by Company
4.5.1 Top Daratumumab Injection Players in United States, Ranked by Revenue (2021)
4.5.2 United States Daratumumab Injection Revenue by Players (2020, 2021 & 2022)

5 Global Daratumumab Injection Market Size by Region
5.1 Global Daratumumab Injection Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Daratumumab Injection Market Size by Region (2017-2028)
5.2.1 Global Daratumumab Injection Market Size by Region: 2017-2022
5.2.2 Global Daratumumab Injection Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Daratumumab Injection Market Size YoY Growth 2017-2028
6.1.2 North America Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Daratumumab Injection Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Daratumumab Injection Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Daratumumab Injection Market Size YoY Growth 2017-2028
6.3.2 Europe Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Daratumumab Injection Market Size YoY Growth 2017-2028
6.4.2 Latin America Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Daratumumab Injection Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Details
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Daratumumab Injection Introduction
7.1.4 Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022)
7.1.5 Johnson & Johnson Recent Development
7.2 Xi'an Janssen Pharmaceutical
7.2.1 Xi'an Janssen Pharmaceutical Company Details
7.2.2 Xi'an Janssen Pharmaceutical Business Overview
7.2.3 Xi'an Janssen Pharmaceutical Daratumumab Injection Introduction
7.2.4 Xi'an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022)
7.2.5 Xi'an Janssen Pharmaceutical Recent Development
7.3 Shanghai Henlius Biotech
7.3.1 Shanghai Henlius Biotech Company Details
7.3.2 Shanghai Henlius Biotech Business Overview
7.3.3 Shanghai Henlius Biotech Daratumumab Injection Introduction
7.3.4 Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022)
7.3.5 Shanghai Henlius Biotech Recent Development

8 Research Findings and Conclusion

9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

If you would like to get a FREE sample, place an order, or have any questions, please enter

https://us.qyresearch.com/reports/347326/daratumumab-injection

Any doubts and questions will be welcome.

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us

QY Research

E-mail: global@qyresearch.com

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

This report focuses on global and United States Daratumumab Injection market, also covers the segmentation data of other regions in regional level and county level.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global and United States Daratumumab Injection Market Report & Forecast 2022-2028 here

News-ID: 2597095 • Views:

More Releases from QY Research

Intelligent Servo Drive Market to Reach USD 7,757 Million by 2031 Top 20 Company Globally
Intelligent Servo Drive Market to Reach USD 7,757 Million by 2031 Top 20 Company …
The intelligent servo drive industry sits at the intersection of precision motion control, embedded sensing, and factory-level data software. Intelligent servo drives combine power electronics, digital control algorithms, and increasingly rich sensor and communications stacks (Ethernet/fieldbus, safety protocols and condition monitoring) to deliver high-bandwidth position, speed and torque control while also acting as distributed data sources for predictive maintenance and OEE improvements. Demand is driven by broader factory automation, robotics,
Phosphate Free Degreaser Market to Reach USD 963 Million by 2031 Top 10 Company Globally
Phosphate Free Degreaser Market to Reach USD 963 Million by 2031 Top 10 Company …
Phosphate-free degreasers are cleaning formulations designed to remove oils, greases, and industrial soils without using phosphate salts (phosphates), a class of ingredients increasingly restricted for environmental reasons. These products span water-based detergents, solvent-substitutes and powdered formulations used across automotive, metal-working, food-processing and institutional cleaning applications. The shift away from phosphate chemistry is driven by tighter regulatory pressure on phosphorus discharge to waterways, rising demand for sustainable formulations, and growing customer
Ultrasonic Blind Spot Detection Sensor Market to Reach CAGR 8,2% by 2031 Top 15 Company Globally
Ultrasonic Blind Spot Detection Sensor Market to Reach CAGR 8,2% by 2031 Top 15 …
The ultrasonic blind spot detection sensor market occupies a specialized niche within automotive advanced driver-assistance systems (ADAS), using short-range ultrasonic transducers and signal-processing electronics to detect nearby objects and warn drivers during lane changes or parking maneuvers. These systems are valued for simplicity, low cost, robustness in short-range scenarios and easy integration with vehicle electronics; they commonly complement radar and camera-based solutions rather than replace them. In 2024 the ultrasonic blind
Switching Residential Voltage Regulators Market to Reach CAGR 8.1% by 2031 Top 20 Company Globally
Switching Residential Voltage Regulators Market to Reach CAGR 8.1% by 2031 Top 2 …
The Switching Residential Voltage Regulator industry sits at the intersection of power-electronics miniaturization and growing homeowner demand for stable, appliance-safe electricity; these devices use switching (DC-DC or AC-DC with switching stages) architectures to deliver higher efficiency and lower heat than linear alternatives while protecting residential equipment from brownouts, surges and line noise. The industrys end markets span stand-alone home voltage conditioners, integrated smart-home power modules, small generator AVRs, and distribution-level

All 5 Releases


More Releases for Daratumumab

Daratumumab Injection Market to Reach USD 1,818 Million by 2031 Top 10 Company G …
Daratumumab is a CD38-directed monoclonal antibody used primarily to treat multiple myeloma and related plasma-cell disorders; marketed as DARZALEX® (intravenous) and DARZALEX FASPRO® (subcutaneous coformulation with hyaluronidase), the medicine transformed the myeloma treatment landscape by moving from a late-line to a broad frontline and maintenance role in combination regimens, and by offering an SC formulation that materially shortens administration time and improves clinic throughput. Commercial value is driven by labeled
Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Mark …
What combination of drivers is leading to accelerated growth in the daratumumab or darzalex market? The escalation of bone marrow cancer occurrences is anticipated to stimulate the expansion of the daratumumab or darzalex market. Bone marrow cancer entails cancers initiating in the bone marrow like multiple myeloma and leukemia which disrupt normal bodily functions due to abnormal blood cell production. The surge in bone marrow cancers is linked to an ageing
Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Mark …
What combination of drivers is leading to accelerated growth in the daratumumab or darzalex market? The escalation of bone marrow cancer occurrences is anticipated to stimulate the expansion of the daratumumab or darzalex market. Bone marrow cancer entails cancers initiating in the bone marrow like multiple myeloma and leukemia which disrupt normal bodily functions due to abnormal blood cell production. The surge in bone marrow cancers is linked to an ageing
Key Trend Reshaping the Daratumumab Or Darzalex Market in 2025: Focus On Transme …
What Are the Projections for the Size and Growth Rate of the Daratumumab Or Darzalex Market? The market for daratumumab, also known as darzalex, has experienced swift expansion in the last few years. It is projected to escalate from $5,093.04 million in 2024 to $5,618.30 million in 2025 with a compound annual growth rate (CAGR) of 10.3%. This substantial growth during the historic period is primarily due to the use of
Genmab/Janssen Biotech's Daratumumab market size expected to increase many folds …
DelveInsight has recently published a report on "Daratumumab Market Forecast Report" providing an in-depth analysis of the Daratumumab market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of Daratumumab market potential and market share analysis in the AL Amyloidosis therapeutics space across the 7MM from
Daratumumab Market Size, SWOT Analysis, Growth Statistics, Prominent Players Str …
This comprehensive Report of the Daratumumab Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their place and survive in